Workflow
cbdMD(YCBD)
icon
Search documents
cbdMD(YCBD) - 2022 Q4 - Earnings Call Transcript
2023-02-14 00:37
cbdMD, Inc. (NYSE:YCBD) Q4 2022 Earnings Conference Call February 13, 2022 4:15 PM ET Company Participants Brad Whitford - VP of Finance Ronan Kennedy - CFO and COO Kevin MacDermott - President Conference Call Participants Operator Good afternoon. Welcome to cbdMD Inc.'s December 31, 2022 First Quarter of Fiscal 2023 Earnings Call and Update. This afternoon, the company issued a press release that provided an overview of its first quarter results, which followed the filing of its quarterly report on Form 10 ...
cbdMD(YCBD) - 2023 Q1 - Quarterly Report
2023-02-13 21:06
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 8845 Red Oak Blvd, Charlotte, NC 28217 Address of Principal Executive Offices Zip Code 704-445-3060 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________________ to _______________ ...
cbdMD(YCBD) - 2022 Q4 - Annual Report
2022-12-15 21:05
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to __________ Commission file number 001-38299 cbdMD, INC. (Exact Name of Registrant as Specified in its Charter) | North Carolina | 47-3414576 | | --- | --- | | State or Other Jurisdiction of | I.R.S. Employer | | Incorporation or Organization | Identification No. | | 8845 Red O ...
cbdMD(YCBD) - 2022 Q3 - Earnings Call Transcript
2022-08-13 20:14
cbdMD, Inc. (NYSE:YCBD) Q3 2022 Results Conference Call August 11, 2022 4:30 PM ET Company Participants Ronan Kennedy - CFO and COO Scott Stephen - Chairman Kevin MacDermott - President Dr. Sibyl Swift - Vice President of Scientific and Regulatory Affairs Conference Call Participants Jeff Porter - Porter Capital Management Operator Good afternoon. Welcome to the cbdMD Inc.'s June 30, 2022 Third Quarter of Fiscal 2022 Earnings Call and Update. This afternoon, the Company issued a press release that provided ...
cbdMD(YCBD) - 2022 Q3 - Quarterly Report
2022-08-11 20:21
Table of Contents Commission file number 001-38299 cbdMD, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________________ to _______________ (Exact Name of Registrant as Specified in its Charter) Nor ...
cbdMD(YCBD) - 2022 Q2 - Earnings Call Transcript
2022-05-17 23:22
cbdMD, Inc. (NYSE:YCBD) Q2 2022 Earnings Conference Call May 13, 2022 4:30 PM ET Company Participants Ronan Kennedy - CFO and COO Marty Sumichrast - Chairman and Co-CEO Sibyl Swift - VP, Scientific & Regulatory Affairs Conference Call Participants Operator Good afternoon, and welcome to cbdMD, Inc.'s March 31, 2022, Second Quarter of Fiscal 2022 Earnings Call and Update. This afternoon, the company issued a press release that provided an overview of its second quarter of fiscal year 2022 results, which foll ...
cbdMD(YCBD) - 2022 Q2 - Quarterly Report
2022-05-13 20:07
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________________ to _______________ Commission file number 001-38299 cbdMD, INC. (Exact Name of Registrant as Specified in its Charter) North Carolina 47-34 ...
cbdMD(YCBD) - 2022 Q1 - Earnings Call Transcript
2022-02-11 01:22
cbdMD, Inc. (NYSE:YCBD) Q1 2022 Earnings Conference Call February 10, 2022 4:15 PM ET Company Participants Ronan Kennedy – Chief Financial Officer and Chief Operating Officer Marty Sumichrast – Chairman and Co-Chief Executive Officer Sibyl Swift – Vice President-Scientific & Regulatory Affairs Conference Call Participants Mike Pfeffer – Oppenheimer Operator Welcome to cbdMD’s December 31, 2021 First Quarter Earnings Call and Update. This afternoon, the company issued a press release that provided an overvie ...
cbdMD(YCBD) - 2022 Q1 - Quarterly Report
2022-02-10 21:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________________ to _______________ Commission file number 001-38299 cbdMD, INC. (Exact Name of Registrant as Specified in its Charter) North Carolina 47 ...
cbdMD(YCBD) - 2021 Q4 - Earnings Call Transcript
2021-12-18 00:33
cbdMD, Inc. (NYSE:YCBD) Q4 2021 Earnings Conference Call December 17, 2021 4:15 PM ET Company Participants Ronan Kennedy - CFO, COO, Secretary & Treasurer Marty Sumichrast - Chairman & Co-CEO Sibyl Swift - VP, Scientific and Regulatory Affairs Conference Call Participants Hunter Diamond - Diamond Equity Operator Good afternoon. Welcome to cbdMD Inc.’s September 30, 2021 Fourth Quarter and Fiscal Year 2021 Earnings Call and Update. This afternoon, the company issued a press release that provided an overview ...